Cue Health Return on Investment 2020-2023 | HLTH
Current and historical return on investment (ROI) values for Cue Health (HLTH) over the last 10 years.
| Cue Health ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2023-12-31 | $-0.40B | -318.55% | |
| 2023-09-30 | $-0.29B | -106.24% | |
| 2023-06-30 | $-0.29B | -68.99% | |
| 2023-03-31 | $-0.30B | $0.50B | -52.73% |
| 2022-12-31 | $-0.21B | $0.58B | -32.31% |
| 2022-09-30 | $-0.14B | $0.59B | -21.42% |
| 2022-06-30 | $0.01B | $0.64B | 1.61% |
| 2022-03-31 | $0.18B | $0.73B | 33.97% |
| 2021-12-31 | $0.19B | $0.71B | 55.56% |
| 2021-06-30 | $0.07B | inf% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.026B | $0.071B |
| Cue Health Inc. is a health technology company. It offers individuals, enterprises, government agencies and healthcare provides access to lab-quality diagnostic testing at home, at work or at the point-of-care, all in a device. Cue Health Inc. is headquartered in San Diego. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $39.372B | 21.90 |
| Inspire Medical Systems (INSP) | United States | $7.021B | 0.00 |
| 10x Genomics (TXG) | United States | $4.117B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.520B | 0.00 |
| Axonics (AXNX) | United States | $3.448B | 0.00 |
| Enovis (ENOV) | United States | $3.211B | 24.40 |
| Azenta (AZTA) | United States | $3.053B | 248.86 |
| Hims & Hers Health (HIMS) | United States | $2.991B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.838B | 0.00 |
| Privia Health (PRVA) | United States | $2.200B | 97.58 |
| Schrodinger (SDGR) | United States | $1.913B | 0.00 |
| Phreesia (PHR) | United States | $1.330B | 0.00 |
| Omnicell (OMCL) | United States | $1.248B | 30.54 |
| Definitive Healthcare (DH) | United States | $0.866B | 0.00 |
| Standard BioTools (LAB) | United States | $0.809B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.621B | 0.00 |
| Talkspace (TALK) | United States | $0.588B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.357B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.332B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.326B | 0.00 |
| Pulmonx (LUNG) | United States | $0.304B | 0.00 |
| Augmedix (AUGX) | United States | $0.186B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.185B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.185B | 0.00 |
| American Well (AMWL) | United States | $0.166B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.158B | 0.00 |
| TruBridge (TBRG) | United States | $0.129B | 5.49 |
| Outset Medical (OM) | United States | $0.106B | 0.00 |
| 111 (YI) | China | $0.092B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.082B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.076B | 0.00 |
| Zepp Health (ZEPP) | China | $0.055B | 0.00 |
| HeartBeam (BEAT) | United States | $0.051B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.046B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.036B | 0.00 |
| Movano (MOVE) | United States | $0.029B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.024B | 0.00 |
| Akili (AKLI) | United States | $0.021B | 0.00 |
| ETAO (ETAO) | United States | $0.020B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.018B | 0.00 |
| Centogene (CNTG) | Germany | $0.015B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| Transgenomic (PRPO) | United States | $0.010B | 0.00 |
| Syra Health (SYRA) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Motus GI Holdings (MOTS) | United States | $0.001B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |